ABC Arbitrage’s Astria Therapeutics ATXS Stock Holding History

ABC Arbitrage’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-517,207	Closed	-$6.77M	–	370
2025 Q4	$6.77M	Buy	+517,207	New	+$6.18M	0.63%	31

ABC Arbitrage's ATXS Position: Q1 2026 in Review

ABC Arbitrage sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 517,207 shares — an estimated $6.77M sold.

ABC Arbitrage first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $6.77M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

ABC Arbitrage reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
ABC Arbitrage sold 517,207 Astria Therapeutics shares in Q1 2026, an estimated $6.77M.
ABC Arbitrage first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
ABC Arbitrage's Astria Therapeutics position peaked at $6.77M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on ABC Arbitrage's 13F filing for Q1 2026, filed 4 May 2026.